참고문헌
- Chrousos, G. P. : The HPA axis and the stress response. Endocr. Res. 26, 513 (2000). https://doi.org/10.3109/07435800009048562
- Wilckens, T. : Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. Trends Pharmacol. Sci. 16, 193 (1995). https://doi.org/10.1016/S0165-6147(00)89021-5
- Annane, D., Bellissant, E. and Bollaert, P. E. : Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 301, 2362 (2009). https://doi.org/10.1001/jama.2009.815
- Chrousos, G. P. : The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture. Ann. N. Y. Acad. Sci. 917, 38 (2000).
- Chrousos, G. P. : Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J. Allergy Clin. Immunol. 106(5 Suppl), S275 (2000). https://doi.org/10.1067/mai.2000.110163
- Constantinopoulos, P., Michalaki, M., Kottorou, A., Habeos, I., Psyrogiannis, A., Kalfarentzos, F. and Kyriazopoulou, V. : Cortisol in tissue and systemic level as a contributing factor to the development of metabolic syndrome in severely obese patients. Eur. J. Endocrinol. 172, 69 ( 2015).
- van Raalte, D. H., Ouwens, D. M. and Diamant, M. : Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur. J. Clin. Invest. 39, 81 (2009). https://doi.org/10.1111/j.1365-2362.2008.02067.x
- Pasquali, R., Vicennati, V., Cacciari, M. and Pagotto, U. : The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann. N. Y. Acad. Sci. 1083, 111 (2006). https://doi.org/10.1196/annals.1367.009
- Wolf, G. : Glucocorticoids in adipocytes stimulate visceral obesity. Nutr. Rev. 60(5 Pt 1), 148 (2002). https://doi.org/10.1301/00296640260093823
- Chrousos, G. P. : The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332, 1351 (1995). https://doi.org/10.1056/NEJM199505183322008
- Morrison, D. C. and Ryan J. L. : Bacterial endotoxins and host immune responses. Adv. Immunol. 28, 293 (1979).
- Rojas, M., Woods, C. R., Mora, A. L., Xu, J. and Brigham, K. L. : Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses. Am. J. Physiol. Lung Cell Mol. Physiol. 288, L333 (2005). https://doi.org/10.1152/ajplung.00334.2004
- Bastard, J. P., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J. and Feve, B. : Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4 (2006).
- Kanczkowski, W., Sue, M., Zacharowski, K., Reincke, M. and Bornstein, S. R. : The role of adrenal gland microenvironment in the HPA axis function and dysfunction during sepsis. Mol. Cell. Endocrinol. S0303-7207, 00422 (2014).
- Briegel, J. : Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications. Wien. Klin. Wochenschr. 114(Suppl 1), 9 (2002).
- Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., Laterre, P. F., Reinhart, K., Cuthbertson, B. H., Payen, D. and Briegel, J. : CORTICUS Study Group : Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 358, 111 (2008). https://doi.org/10.1056/NEJMoa071366
- Smyth, G. P., Stapleton, P. P., Freeman, T. A., Concannon, E. M., Mestre, J. R., Duff, M., Maddali, S. and Daly, J. M. : Glucocorticoid pretreatment induces cytokine overexpression and nuclear factor-kappaB activation in macrophages. J. Surg. Res. 116, 253 (2004). https://doi.org/10.1016/S0022-4804(03)00300-7
- Fantuzzi, G., Demitri, M. T. and Ghezzi, P. : Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone. Clin. Exp. Immunol. 96, 166 (1994).
- Yeager, M. P., Rassias, A. J., Pioli, P. A., Beach, M. L., Wardwell, K., Collins, J. E., Lee, H. K. and Guyre, P. M. : Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin. Crit. Care Med. 37, 2727 (2009). https://doi.org/10.1097/CCM.0b013e3181a592b3
- Barber, A. E., Coyle, S. M., Marano, M. A., Fischer, E., Calvano, S. E., Fong, Y., Moldawer, L. L. and Lowry, S. F. : Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol. 150, 1999 (1993).
- Morrow, L. E., McClellan, J. L., Conn, C. A. and Kluger, M. J. : Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am. J. Physiol. 264(5 Pt 2), R1010 (1993).
- Zhou, D., Kusnecov, A. W., Shurin, M. R., DePaoli, M. and Rabin, B. S. : Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133, 2523 (1993). https://doi.org/10.1210/endo.133.6.8243274
- Permana P. A., Menge, C. and Reaven, P. D. : Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem. Biophys. Res. Commun. 341, 507 (2006). https://doi.org/10.1016/j.bbrc.2006.01.012
- Tack, C. J., Stienstra, R., Joosten, L. A. and Netea, M. G. : Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol. Rev. 249, 239 (2012). https://doi.org/10.1111/j.1600-065X.2012.01145.x
- Snyers, L., De Wit, L. and Content, J. : Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc. Natl. Acad. Sci. USA 87, 2838 (1990). https://doi.org/10.1073/pnas.87.7.2838
- Puchner, A. and Bluml, S. : IL-6 blockade in chronic inflammatory diseases. Wien. Med. Wochenschr. 165, 14 (2014).
- Shacter, E., Arzadon, G. K. and Williams, J. : Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: Inhibition by Indomethacin. Blood 80, 194 (1992).
- Kim, H. J., Higashimori, T., Park, S. Y., Choi, H., Dong, J., Kim, Y. J., Noh, H. L., Cho, Y. R., Cline, G., Kim, J. H., Bachmann, R. A. and Chen, J. : Interleukin-6 and insulin resistance. Vitam. Horm. 80, 613 (2009). https://doi.org/10.1016/S0083-6729(08)00621-3
- Kiecolt-Glaser, J. K., Preacher, K. J., MacCallum, R. C., Atkinson, C., Malarkey, W. B. and Glaser, R. : Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 100, 9090 (2003). https://doi.org/10.1073/pnas.1531903100
- Depraetere, S., Willems, J. and Joniau, M. : Stimulation of CRP secretion in HepG2 cells: cooperative effect of dexamethasone and interleukin 6. Agents Actions. 34, 369 (1991). https://doi.org/10.1007/BF01988730
- Mastorakos, G., Weber, J. S., Magiakou, M. A., Gunn, H. and Chrousos, G. P. : Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J. Clin. Endocrinol. Metab. 79, 934 (1994).
- Briancon-Marjollet, A., Pepin, J. L., Weiss, J. W., Levy, P. and Tamisier, R. : Intermittent hypoxia upregulates serum VEGF. Sleep Med. 15, 1425 (2014). https://doi.org/10.1016/j.sleep.2014.07.006
- Segi-Nishida, E., Warner-Schmidt, J. L. and Duman, R. S. : Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proc. Natl. Acad. Sci. USA 105, 11352 (2008). https://doi.org/10.1073/pnas.0710858105
- Koczy-Baron, E. and Kasperska-Zajac, A. : The role of vascular endothelial growth factor in inflammatory processes. Postepy. Hig. Med. Dosw. (Online) 68, 57 (2014). https://doi.org/10.5604/17322693.1086360
- Tang, X., Yang, Y., Yuan, H., You, J., Burkatovskaya, M. and Amar, S. : Novel transcriptional regulation of VEGF in inflammatory processes. J. Cell. Mol. Med. 17, 386 (2013). https://doi.org/10.1111/jcmm.12020
- Yano, K., Liaw, P. C., Mullington, J. M., Shih, S. C., Okada, H., Bodyak, N., Kang, P. M., Toltl, L., Belikoff, B., Buras, J., Simms, B. T., Mizgerd, J. P., Carmeliet, P., Karumanchi, S. A. and Aird, W. C. : Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J. Exp. Med. 203, 1447 (2006). https://doi.org/10.1084/jem.20060375
- Gao, T., Lin, Z. and Jin, X. : Hydrocortisone suppression of the expression of VEGF may relate to toll-like re ceptor (TLR) 2 and 4. Curr. Eye Res. 34, 777 (2009). https://doi.org/10.1080/02713680903067919
- Carvalho, L. A., Torre, J. P., Papadopoulos, A. S., Poon, L., Juruena, M. F., Markopoulou, K., Cleare, A. J. and Pariante, C. M. : Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. J. Affect Disord. 148, 136 (2013). https://doi.org/10.1016/j.jad.2012.10.036
- Perreault, M. and Marette, A. : Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7, 1138 (2001). https://doi.org/10.1038/nm1001-1138
- Radomski, M. W., Palmer, R. M. J. and Moncada, S. : Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87, 10043 (1990). https://doi.org/10.1073/pnas.87.24.10043